IOSP
INNOSPEC INC.
NASDAQ · Basic Materials · Chemicals - Specialty · US
$82.20
−17.16%Year over year
Reported trailing growth
- Revenue
- -74.5%
- EBITDA
- -67.0%
- EBIT
- +10.7%
- EPS
- +3920.0%
- Free cash flow
- +1.1%
- Operating cash flow
- +1.0%
Forward estimates
Based on analyst estimates
- Revenue
- +345.1%
- EBITDA
- +309.0%
- EPS
- +215.6%
Three-year CAGR
- Revenue
- -3.3%
- EBITDA
- -7.0%
- EBIT
- -5.9%
- Net income
- -4.3%
- EPS
- -4.4%
- Free cash flow
- +30.7%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Sep 1, 2026